NTQ1062 Chemical Structure oral Akt inhibitor - Nanjing Chia-Tai Tianqing Pharmaceutical Co., Ltd., Nanjing, CN

oral Akt inhibitor

Ph. I in advanced solid tumors

scaffold hopping and PK opt.

J. Med. Chem.

Nanjing Chia-Tai Tianqing Pharmaceutical Co., Ltd., Nanjing, CN

Context. NTQ1062 (Nanjing Chia-Tai Tianqing; CTTQ) is an oral ATP-competitive Akt inhibitor being developed for cancer. Because the PI3K/Akt/mTOR pathway is one of the most commonly disrupted pathways in…


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.